Filing Details

Accession Number:
0001181431-13-011014
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-20 17:09:01
Reporting Period:
2013-02-15
Filing Date:
2013-02-20
Accepted Time:
2013-02-20 17:09:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
860730 Hca Holdings Inc. HCA Services-General Medical & Surgical Hospitals, Nec (8062) 273865930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1213395 John Connaughton C/O Bain Capital Partners, Llc
John Hancock Tower, 200 Clarendon St
Boston MA 02116
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Disposition 2013-02-15 23,576,519 $35.87 50,331,374 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnotes
Footnotes
  1. The shares of HCA Holdings, Inc. ("HCA") reported on this Form 4 are held of record by Hercules Holding II, LLC ("Hercules II"). Hercules II is held by a private investor group, including affiliates of Bain Capital Investors, LLC ("BCI"), Kohlberg Kravis & Roberts & Co. LLC and affiliates of HCA founder Dr. Thomas F. Frist, Jr. Affiliates of BCI indirectly own 50,331,374 shares of Common Stock of HCA.
  2. Includes 21,887,938 shares of HCA indirectly sold by Bain Capital Integral Investors, 2006, LLC ("Integral 2006") by virtue of its membership in Hercules II, Mr. Connaughton is a Managing Director of BCI. Because BCI is the administrative member of Integral 2006, Mr. Connaughton may be deemed to beneficially own the 46,773,097 shares of Common Stock of HCA indirectly owned by Integral 2006 by virtue of its membership in Hercules II. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  3. Includes 160,098 shares of HCA indirectly sold by BCIP TCV, LLC ("BCIP TCV") by virtue of its membership in Hercules II. Because BCI is the administrative member of BCIP TCV, Mr. Connaughton may be deemed to beneficially own the 337,368 shares of Common Stock of HCA indirectly owned by BCIP TCV by virtue of its membership in Hercules II. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  4. Included 1,528,483 shares of HCA indirectly sold by Bain Capital Hercules Investors, LLC ("Hercules Investors" together with BCI, Integral 2006 and BCIP TCV, the "Bain Entities") by virtue of its membership in Hercules II. Because BCI is the administrative member of Hercules Investors, Mr. Connaughton may be deemed to beneficially own the 3,220,909 shares of Common Stock of HCA indirectly owned by Hercules Investors by virtue of its membership in Hercules II. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  5. As a result of the relationships described in the foregoing footnotes, Mr. Connaughton may be deemed to beneficially own the 174,275,052 shares of Common Stock of HCA held by Hercules II. Mr. Connaughton disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.